Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/12/2013 | CN103142579A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
06/12/2013 | CN103142578A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
06/12/2013 | CN103142576A Application of salvianolic acid A freeze-dried powder to preparation of drug for protecting cerebral vascular endothelial cells |
06/12/2013 | CN103142575A Application of salvianolic acid A freeze-dried powder to preparation of drug for inhibiting neuronal damage or death of brain tissue |
06/12/2013 | CN103142574A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
06/12/2013 | CN103142573A Application of salvianolic acid A freeze-dried powder to preparation of drug for improving symptom of neurological function after cerebral ischemia |
06/12/2013 | CN103142572A Salvianolic acid A tablet and application thereof to medicine preparation |
06/12/2013 | CN103142562A Sustained-release sticking film for treating oral ulcer |
06/12/2013 | CN103142561A Cataplasm basic material and preparation method thereof |
06/12/2013 | CN103142560A Montelukast sodium film-like preparation |
06/12/2013 | CN103142559A Risperidone film-like preparation |
06/12/2013 | CN103142558A Diclofenac sodium dual-release enteric-coated preparation, as well as preparation method and control method thereof |
06/12/2013 | CN103142557A Polymannuronate sulfate slow release capsule and preparation method thereof |
06/12/2013 | CN103142556A Polysaccharide sulfate sustained-release capsule and preparation method thereof |
06/12/2013 | CN103142555A Alfacalcidol sustained-release capsule and preparation method thereof |
06/12/2013 | CN103142554A Calcitriol controlled-release capsule and preparation method thereof |
06/12/2013 | CN103142553A Calcitriol sustained-release capsule and preparation method thereof |
06/12/2013 | CN103142552A Lovastatin enteric coated sustained-release pellet capsule and preparation method thereof |
06/12/2013 | CN103142551A Method for preparing micro-capsule by taking xanthan gum and gelatine as wall materials through complex coacervation method |
06/12/2013 | CN103142550A Microcapsule prepared based on interfacial polycondensation method and preparation method thereof |
06/12/2013 | CN103142549A Mannose ester enteric capsule and preparation method thereof |
06/12/2013 | CN103142548A Colloidal bismuth pectin capsule |
06/12/2013 | CN103142547A Calcitriol enteric capsule and preparation method thereof |
06/12/2013 | CN103142546A Calcitriol capsule and preparation method thereof |
06/12/2013 | CN103142545A Enteric capsule of etoposide |
06/12/2013 | CN103142544A Ubenimex capsule composition and preparation method thereof |
06/12/2013 | CN103142543A Salvianolic acid A capsule and application thereof to medicine preparation |
06/12/2013 | CN103142542A Salvianolic acid A capsule and application thereof to medicine preparation |
06/12/2013 | CN103142541A Stable montelukast sodium capsule |
06/12/2013 | CN103142540A PGMS (Propylene Glycol Mannate Sulfate) controlled-release tablet and preparation method thereof |
06/12/2013 | CN103142539A Alginic sodium diester controlled-release tablet and preparation method thereof |
06/12/2013 | CN103142538A PGMS (Propylene Glycol Mannate Sulfate) enteric tablet and preparation method thereof |
06/12/2013 | CN103142537A Calcitriol slow-release preparation troche |
06/12/2013 | CN103142536A Calcitriol enteric tablet and preparation method thereof |
06/12/2013 | CN103142535A Alginic sodium diester enteric tablet and preparation method thereof |
06/12/2013 | CN103142534A Calcitriol controlled-release tablet and preparation method thereof |
06/12/2013 | CN103142533A Enteric coated tablet of etoposide |
06/12/2013 | CN103142532A Ginkgolide osmotic pump tablet and preparation method thereof |
06/12/2013 | CN103142531A Aspirin slow release tablet and preparation method thereof |
06/12/2013 | CN103142530A Sustained-release tablet of etoposide |
06/12/2013 | CN103142529A Indapamide sustained-release drug composite and preparation method thereof |
06/12/2013 | CN103142528A Troche of chick embryo polysaccharide |
06/12/2013 | CN103142527A Entecavir potassium tablet and preparation method thereof |
06/12/2013 | CN103142526A Dropping pills containing colloidal bismuth pectin |
06/12/2013 | CN103142525A Olanzapine gastric soluble tablets and preparation method thereof |
06/12/2013 | CN103142524A Calcitriol tablet and preparation method thereof |
06/12/2013 | CN103142523A Dropping pills containing etoposide |
06/12/2013 | CN103142522A 一种依托泊苷片剂 One kind of etoposide tablet |
06/12/2013 | CN103142521A Glibenclamide tablet and preparation method thereof |
06/12/2013 | CN103142520A Kelimycin tablet and preparation method thereof |
06/12/2013 | CN103142519A Levocarnitine tablets and preparation method thereof |
06/12/2013 | CN103142518A Alogliptin liposome solid preparation as well as preparation method and application thereof |
06/12/2013 | CN103142517A Salvianolic acid A dropping pill and application thereof to medicine preparation |
06/12/2013 | CN103142516A Salvianolic acid A dropping pill and application thereof to medicine preparation |
06/12/2013 | CN103142515A Asarone injection and preparation method thereof |
06/12/2013 | CN103142514A Lyophilized composition for injection containing thymalfasin and preparation method thereof |
06/12/2013 | CN103142513A Racemized 2-(alpha-hydroxypentyl) benzoate freeze-dried powder needle for injection, and preparation method thereof |
06/12/2013 | CN103142512A High-quality composition containing oxaliplatin and preparation method of composition |
06/12/2013 | CN103142511A High-purity and high-stability composition containing oxaliplatin and preparation method of composition |
06/12/2013 | CN103142510A Injection containing moxifloxacin hydrochloride composition |
06/12/2013 | CN103142509A Bortezomib pharmaceutic composition for injection |
06/12/2013 | CN103142508A Application of salvianolic acid A freeze-dried powder to preparation of drug for protecting ischemia brain tissue damage |
06/12/2013 | CN103142507A Clindamycin phosphate preparation for injection and preparation method thereof |
06/12/2013 | CN103142506A Cefpodoxime proxetil granules and preparation method thereof |
06/12/2013 | CN103142505A Acetylcysteine composition granules and preparation method thereof |
06/12/2013 | CN103142504A PGMS (Propylene Glycol Mannate Sulfate) sustained-release granule and preparation method thereof |
06/12/2013 | CN103142503A Alfacalcidol sustained-release granule and preparation method thereof |
06/12/2013 | CN103142502A Calcitriol sustained-release granule and preparation method thereof |
06/12/2013 | CN103142501A Calcitriol pellet and preparation method thereof |
06/12/2013 | CN103142500A Sustained-release particle of etoposide |
06/12/2013 | CN103142499A 一种依托泊苷颗粒 One kind of particle etoposide |
06/12/2013 | CN103142498A Calcitriol enteric granule and preparation method thereof |
06/12/2013 | CN103142497A Enteric granule of etoposide |
06/12/2013 | CN103142496A Calcitriol controlled-release granule and preparation method thereof |
06/12/2013 | CN103142495A Calcitriol suspension granule and preparation method thereof |
06/12/2013 | CN103142494A Ornidazole oral preparation and preparation method thereof |
06/12/2013 | CN103142493A Process for preparing cefuroxime axetil granule medicament composition |
06/12/2013 | CN103142492A Controlled release pellet preparation and its preparation method |
06/12/2013 | CN103142491A Vidarabine monophosphate microsphere drug delivery system and preparation method thereof |
06/12/2013 | CN103142490A Nesiritide acetate sustained-release microsphere preparation and preparation method thereof |
06/12/2013 | CN103142489A Human alpha-atrial natriuretic peptide sustained release microsphere preparation and preparation method thereof |
06/12/2013 | CN103142488A GLP-I analogue liraglutide sustained-release microspheres and preparation method thereof |
06/12/2013 | CN103142487A High-content toltrazuril soluble powder, as well as preparation method and application thereof |
06/12/2013 | CN103142486A Calcitriol powder and preparation method thereof |
06/12/2013 | CN103142485A Etoposide dry suspension |
06/12/2013 | CN103142484A Fenofibrate lipid cubic liquid crystal solid powder and preparation method thereof |
06/12/2013 | CN103142483A Dry suspension of mannose ester, and its preparation method |
06/12/2013 | CN103142482A Preparation method for nanoparticle pharmaceutical composition, and nanoparticle pharmaceutical composition |
06/12/2013 | CN103142481A Drug-loaded liposome overcoming tumor drug resistance, preparation method and application thereof |
06/12/2013 | CN103142480A Febuxostat nanoliposome and purpose |
06/12/2013 | CN103142479A Application of phospholipid-Vitamin E tocopherol acid polyethylene glycol succinate micelle |
06/12/2013 | CN103142478A Calcitriol emulsion and preparation method thereof |
06/12/2013 | CN103142477A Preparation method of sustained-release colchicine micro emulsion preparation containing nanometer-carrier |
06/12/2013 | CN103142476A Calcitriol suspension and preparation method thereof |
06/12/2013 | CN103142475A Exenatideacetate sustained-release microsphere preparation and preparation method thereof |
06/12/2013 | CN103142474A Composition taking high-purity ginkgolide B as active ingredient and preparation method thereof |
06/12/2013 | CN103142473A Composition containing high purity bilobalide B and preparation method thereof |
06/12/2013 | CN103142472A Ginkgolide B composition and preparation method thereof |
06/12/2013 | CN103142471A Calcitriol solution and preparation method thereof |
06/12/2013 | CN103142470A Calcitriol injection and preparation method thereof |